Palliative Management of Inoperable Malignant Bowel Obstruction: A Prospective, Open Label, Phase-2 Study at an NCI Comprehensive Cancer Center
Condition:   Malignant Bowel Obstruction Interventions:   Drug: Dexamethasone;   Drug: Metoclopramide;   Drug: Octreotide Sponsors:   Roswell Park Cancer Institute;   National Cancer Institute (NCI) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 22, 2019 Category: Research Source Type: clinical trials

Palliative Management of Inoperable Malignant Bowel Obstruction
Condition:   Malignant Bowel Obstruction Interventions:   Drug: Dexamethasone;   Drug: Metoclopramide;   Drug: Octreotide Sponsors:   Roswell Park Cancer Institute;   National Cancer Institute (NCI) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 22, 2019 Category: Research Source Type: clinical trials

Palliative Management of Inoperable Malignant Bowel Obstruction: A Prospective, Open Label, Phase-2 Study at an NCI Comprehensive Cancer Center
Condition:   Malignant Bowel Obstruction Interventions:   Drug: Dexamethasone;   Drug: Metoclopramide;   Drug: Octreotide Sponsors:   Roswell Park Cancer Institute;   National Cancer Institute (NCI) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 22, 2019 Category: Research Source Type: clinical trials